In this GEMM, the cytokeratin 14 (K14) promoter sequence was used to drive the expression of Cre recombinase, which meant that mice not only developed mammary tumors but also skin tumors (Table 4, Supplementary File S1). Here, KRT14 is linked to skin neoplasm.